RecruitingNot ApplicableNCT03276793

Brain Connectivity in Depression

Using Human Brain Connectivity to Identify the Causal Neuroanatomical Substrate of Depression Symptoms


Sponsor

Brigham and Women's Hospital

Enrollment

260 participants

Start Date

Apr 3, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

This study originally included 140 subjects with medication-refractory depression undergoing 10 Hz transcranial magnetic stimulation (10Hz-TMS) to the left dorsal lateral prefrontal cortex (DLPFC), with the goal of having 60 completers with good quality data. Subjects were recruited from the TMS clinics at Beth Israel Deaconess Medical Center, Brigham \& Women's Hospital, and Butler Hospital. Subjects underwent an hour-long MRI scanning session, an optional DNA-sample collection, up to three 20 minute neuronavigation sessions for marking the site of TMS stimulation, questionnaires, and a behavioral testing battery before and after their TMS treatment course. The task battery included the Emotion Conflict Resolution (ECR) task, Multi-Source Interference Task (MSIT), War Game (Gambling) task, and Associative Learning with Reversal task. Subjects' scores on the Quick Inventory of Depressive Symptomatology (QIDS) and Beck Depression Inventory (BDI) were assessed before and after the TMS course. MRI data was utilized to identify brain regions whose connectivity to the stimulation site co-varies with the aforementioned measures of symptom improvement. This was the only study group until August 30, 2022, and the primary outcome was analyzed for the 10Hz-TMS group. Due to changes in clinical standard of care from 10Hz-TMS to a newer version of TMS termed intermittent theta burst (iTBS), in September 2022 a second group was added to include patients receiving this new form of TMS. This second group included another 100 patients with medication-refractory depression undergoing iTBS to the left dorsal lateral prefrontal cortex (DLPFC), with the intent to have 80 completers. Massachusetts General Hospital was added as a data collection site in lieu of Butler Hospital. Subjects will undergo an hour-long MRI scanning session, up to three 20 minute neuronavigation sessions for marking the site of TMS stimulation, questionnaires, and a behavioral testing battery before and after their TMS treatment course. The task battery will included the Emotion Conflict Resolution (ECR) task, Multi-Source Interference Task (MSIT), Penn Emotion Recognition Test, the Suicide/Death Implicit Association Test, and Associative Learning with Reversal task. Subjects' scores on the Beck Depression Inventory (BDI) were assessed before and after the TMS course. MRI data will be utilized to identify brain regions whose connectivity to the stimulation site co-varies with the aforementioned measures of symptom improvement. Due to a higher dropout rate than anticipated, in March of 2025 an amendment was added to include an additional 20 subjects in the second group's enrollment goal to increase the likelihood of achieving 80 completers.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using brain MRI scans to understand how brain connections change before and after transcranial magnetic stimulation (TMS) — a non-invasive treatment that uses magnetic pulses to stimulate the brain — in patients with depression that has not responded to medications. **You may be eligible if...** - You are 18 or older - You have received or are currently receiving daily TMS treatment for medication-resistant depression at Brigham and Women's Hospital or Massachusetts General Hospital **You may NOT be eligible if...** - You have a significant neurological condition (like Parkinson's disease, stroke, epilepsy, Alzheimer's, multiple sclerosis, or a brain tumor) - You have not responded to an adequate course of electroconvulsive therapy (ECT), or had ECT within the last 3 months - You had a full course of TMS treatment within the past 12 months - You have metal in your head (such as a surgical clip), a pacemaker, cochlear implant, deep brain stimulator, or other electronic implant - You are claustrophobic in the MRI scanner Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMRI scan

Patients will undergo an MRI scan

BEHAVIORALBehavioral testing

Patients will complete a series of cognitive tasks


Locations(4)

Brigham and Women's Hospital

Boston, Massachusetts, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Butler Hospital

Providence, Rhode Island, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03276793


Related Trials